United Kingdom· GB-APID-44460711000001100
Vabysmo 21mg/0.175ml solution for injection pre-filled syringes
A faricimab product containing faricimab, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Faricimab is registered in 14 of 19 countries.
Countries holding a registration under ATC S01LA09 (faricimab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Faricimab · ATC S01LA09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Faricimab
- Manufacturer
- Roche Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- S01LA09
- ATC class
- Faricimab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07613326073691
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Faricimab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVabysmoRoche Registration GmbH
- SpainVABYSMO 120 MG/ML SOLUCION INYECTABLERoche Registration Gmbh
- CzechiaVABYSMORoche Registration GmbH, Grenzach-Wyhlen
- BelgiumVabysmo 120 mg/mlRoche Registration
- SwitzerlandVabysmo 6 mg/0,05 ml, InjektionslösungRoche Pharma (Schweiz) AG
- IrelandVabysmo 120 mg/mL solution for injectionRoche Registration GmbH
- IcelandVabysmoRoche Registration GmbH*
- Japanファリシマブ（遺伝子組換え）中外製薬
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vabysmo
- Liechtenstein · Vabysmo
- Norway · Vabysmo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e8c10fd-f9cb-4295-b460-2a36b52636dd GET /v1/drugs/6e8c10fd-f9cb-4295-b460-2a36b52636dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44460711000001100",
"desc": "Vabysmo 21mg/0.175ml solution for injection pre-filled syringes (Roche Products Ltd)",
"form": "Solution for injection",
"vpid": "44493511000001101",
"source": "dmd",
"vtm_id": "40706211000001101",
"strength": "120 mg",
"substance": "Faricimab",
"ingredient": "Faricimab",
"supplier_code": "2085201000001100"
}See everything about faricimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.